• Targeted prostate specific membrane antigen in prostate cancer and NaI symporter in differentiated thyroid cancer (181)• Fibroblast activation protein has been targeted in multiple cancers (182)• CD20 has been a target for B cell non-Hodgkin lymphoma as well as CD45 in acute myeloid leukemia (182). This evidence concerns the gene FOLH1 and prostate cancer.